News from oasmia pharmaceutical ab A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NYSE:AB)

Apr 20, 2015, 16:04 ET
Oasmia logo

Paclical®, le produit phare de traitement du cancer d'Oasmia, reçoit l'approbation de commercialisation dans la Fédération de Russie

Oasmia Pharmaceutical AB (« Oasmia ») a annoncé aujourd'hui que Paclical, son produit phare de traitement du cancer, a...

Apr 20, 2015, 16:03 ET
Oasmia logo

Oasmias führendes Krebsprodukt Paclical® erhält Marktzulassung in der Russischen Föderation

Oasmia Pharmaceutical AB ("Oasmia") gab heute bekannt, dass sein führendes Krebsprodukt Paclical vom russischen Gesundheitsministerium die...

Apr 20, 2015, 10:00 ET
Oasmia logo

Oasmia's Lead Cancer Product Paclical® Receives Market Approval in the Russian Federation

Oasmia Pharmaceutical AB ("Oasmia") announced today that its lead cancer product Paclical received market authorization in the Russian Federation...

Dec 03, 2013, 03:48 ET

FDA godkänner Oasmias produktionsanläggning i Uppsala

Läkemedelsbolaget Oasmia Pharmaceutical AB (publ) tillkännager idag att bolagets tillverkningsenhet i Uppsala med tillfredställande...

Dec 03, 2013, 02:45 ET

Oasmia meddelar att bolagets tillverkningsenhet i Uppsala har framgångsrikt genomgått FDA-inspektion

Läkemedelsbolaget Oasmia Pharmaceutical AB (publ) tillkännager idag att bolagets tillverkningsenhet i Uppsala med tillfredställande...

Jan 09, 2013, 07:00 ET

Oasmia Pharmaceutical AB and Abbott Sign Global Collaboration Agreement for Canine Oncology Therapies

Oasmia and Abbott have entered into an exclusive global collaboration agreement with respect to Oasmia's two leading animal health product...

Jan 09, 2013, 07:00 ET

Oasmia och Abbott tecknar globalt samarbetsavtal för den veterinäronkologiska marknaden

Oasmia och Abbott har ingått ett exklusivt globalt samarbetsavtal beträffande Oasmias två första produktkandidater inom Animal...

Jan 07, 2013, 09:25 ET

Oasmia Pharmaceutical and Abbott Sign Global Collaboration Agreement for Canine Oncology Therapies

Oasmia and Abbott have entered into an exclusive global collaboration agreement with respect to Oasmia's two leading animal health product...

Jul 15, 2010, 02:59 ET

Oasmia Pharmaceutical AB, Sweden - Listing Prospectus: NASDAQ OMX Stockholm

- A Number of Promising New Product Candidates for Cancer Treatment, Within Both Human and Veterinary Oncology ABOUT OASMIA Oasmia is developing...

Apr 14, 2009, 08:02 ET

Oasmia: FDA Grants Paclical(R) Orphan Drug Designation for Ovarian Cancer in the USA

Oasmia Pharmaceutical, Uppsala, Sweden, has been granted Orphan Drug designation by the USA FDA of Paclical(R) for the treatment of ovarian cancer....